Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 20, 2021

SELL
$21.33 - $35.06 $1.39 Million - $2.28 Million
-65,000 Closed
0 $0
Q2 2021

Jul 30, 2021

BUY
$19.22 - $59.08 $1.25 Million - $3.84 Million
65,000 New
65,000 $1.4 Million

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $266M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Ameraudi Asset Management, Inc. Portfolio

Follow Ameraudi Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameraudi Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameraudi Asset Management, Inc. with notifications on news.